Such augmentation suggests that the cytotoxic effects of classical chemotherapeutics used in the treatment of colorectal carcinoma could be obtained at lower doses and with higher probability for inducing cancer cell death when combined with DNMT inhibitors. Here, DNMT1 is linked to colorectal carcinoma.